Health Advance Inc
Health Advance Inc., a development stage company, operates as an on-line retailer of home medical products in Canada and the United States. It intends to offers aids to daily living, ambulatory, bath safety, core wound care, diabetic, enteral nutrition-feeding, home diagnostics, incontinence, orthopedic, ostomy, pain management, professional use and diagnostic, respiratory, tracheostomy care, spe… Read more
Health Advance Inc (HADV) - Net Assets
Latest net assets as of December 2025: $-140.81K USD
Based on the latest financial reports, Health Advance Inc (HADV) has net assets worth $-140.81K USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($503.75K) and total liabilities ($644.56K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-140.81K |
| % of Total Assets | -27.95% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 252.77 |
Health Advance Inc - Net Assets Trend (2011–2024)
This chart illustrates how Health Advance Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Health Advance Inc (2011–2024)
The table below shows the annual net assets of Health Advance Inc from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-03-31 | $-41.98K | -696.53% |
| 2023-03-31 | $7.04K | -73.63% |
| 2022-03-31 | $26.69K | -83.04% |
| 2021-03-31 | $157.35K | +198.72% |
| 2017-03-31 | $-159.40K | -22.71% |
| 2016-03-31 | $-129.89K | -23.31% |
| 2015-03-31 | $-105.34K | -80.81% |
| 2014-03-31 | $-58.26K | -77.99% |
| 2013-03-31 | $-32.73K | -252.79% |
| 2011-03-31 | $21.42K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Health Advance Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 78044800.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $620.56K | % |
| Other Components | $186.08K | % |
| Total Equity | $-41.98K | 100.00% |
Health Advance Inc Competitors by Market Cap
The table below lists competitors of Health Advance Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nala Digital Commerce Ltd
TA:NALA
|
$25.41K |
|
ASA International Group PLC
LSE:ASAI
|
$25.43K |
|
Outbrain
NYSE:OB
|
$25.43K |
|
Rex Trueform Group Ltd
JSE:RTO
|
$25.45K |
|
MORGAN ADV
BE:MGJ
|
$25.39K |
|
Sandoll Inc.
KO:419120
|
$25.39K |
|
Harmony Energy Income Trust PLC
LSE:HEIT
|
$25.37K |
|
IREN (TZ8.SG)
STU:TZ8
|
$25.35K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Health Advance Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,038 to -41,983, a change of -49,021 (-696.5%).
- Net loss of 49,022 reduced equity.
- Other factors increased equity by 1.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-49.02K | -116.77% |
| Other Changes | $1.00 | +0.0% |
| Total Change | $- | -696.52% |
Book Value vs Market Value Analysis
This analysis compares Health Advance Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-03-31 | $0.00 | $0.00 | x |
| 2013-03-31 | $0.00 | $0.00 | x |
| 2014-03-31 | $0.00 | $0.00 | x |
| 2015-03-31 | $0.00 | $0.00 | x |
| 2016-03-31 | $-0.01 | $0.00 | x |
| 2017-03-31 | $-0.01 | $0.00 | x |
| 2021-03-31 | $0.00 | $0.00 | x |
| 2022-03-31 | $0.00 | $0.00 | x |
| 2023-03-31 | $0.00 | $0.00 | x |
| 2024-03-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Health Advance Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-462.83%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | -318.24% | 0.00% | 0.00x | 1.58x | $-70.32K |
| 2013 | 0.00% | -109156.00% | 0.04x | 0.00x | $-105.88K |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-80.20K |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-61.55K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-54.56K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-13.56K |
| 2021 | 10.77% | 84.74% | 0.09x | 1.36x | $1.21K |
| 2022 | -489.49% | -2007.36% | 0.02x | 11.57x | $-133.33K |
| 2023 | -3831.39% | 0.00% | 0.00x | 72.38x | $-270.36K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-44.82K |
Industry Comparison
This section compares Health Advance Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $265,787,327
- Average return on equity (ROE) among peers: -7.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Health Advance Inc (HADV) | $-140.81K | -318.24% | N/A | $25.40K |
| Alibaba Health Information Technology Limited (ALBBY) | $1.12 Billion | -18.54% | 0.50x | $12.50 Billion |
| Allstar Health Brands Inc (ALST) | $-9.92 Million | 0.00% | 0.00x | $3.83 |
| Bimi International Medical Inc (BIMI) | $-409.66K | 0.00% | 0.00x | $296.83 |
| Blum Holdings Inc (BLMH) | $-4.74 Million | 0.00% | 0.00x | $8.97 Million |
| China Jo-Jo Drugstores Inc (CJJD) | $26.66 Million | -21.17% | 1.52x | $5.94 Million |
| Clicks Group Ltd (CLCGY) | $1.13 Billion | 41.98% | 2.72x | $4.80 Billion |
| China BCT Pharmacy Group Inc (CNBI) | $134.27 Million | 15.68% | 0.82x | $0.96 |
| Dalrada Financial Corp (DFCO) | $4.40 Million | -81.82% | 0.55x | $1.57 Million |
| Healthwarehouse.Com (HEWA) | $-3.10 Million | 0.00% | 0.00x | $720.96 |